Acetaldehyde → 2-(1-ethyl-4-(4-(7-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-c]pyrimidin-5-yl)-1H-pyrazol-1-yl)piperidin-4-yl)acetonitrile
反応式
Cl.[CH3:2][N:3]1[CH:7]=[C:6]([C:8]2[N:13]=[C:12]([C:14]3[CH:15]=[N:16][N:17]([C:19]4([CH2:25][C:26]#[N:27])[CH2:24][CH2:23][NH:22][CH2:21][CH2:20]4)[CH:18]=3)[N:11]3[CH:28]=[CH:29][N:30]=[C:10]3[CH:9]=2)[CH:5]=[N:4]1.[C:31](#N)[CH3:32].C(N(CC)CC)C.C(=O)C.[BH-](OC(C)=O)(OC(C)=O)OC(C)=O.[Na+]>C(=O)(O)[O-].CCOC(C)=O>[CH2:31]([N:22]1[CH2:21][CH2:20][C:19]([CH2:25][C:26]#[N:27])([N:17]2[CH:18]=[C:14]([C:12]3[N:11]4[CH:28]=[CH:29][N:30]=[C:10]4[CH:9]=[C:8]([C:6]4[CH:5]=[N:4][N:3]([CH3:2])[CH:7]=4)[N:13]=3)[CH:15]=[N:16]2)[CH2:24][CH2:23]1)[CH3:32]参加物
反応物 5
生成物 1
試薬・触媒・溶媒 2
実験手順
2-(4-(4-(7-(1-Methyl-1H-pyrazol-4-yl)imidazo[1,2-c]pyrimidin-5-yl)-1H-pyrazol-1-yl)piperidin-4-yl)acetonitrile hydrochloride (Example 28, Step A; 27.0 mg, 0.0543 mmol) was suspended in acetonitrile (543 μL, 0.0543 mmol). To this was added triethylamine (30.3 μL, 0.217 mmol) to freebase, followed by acetaldehyde (30.5 μL, 0.543 mmol). After 30 minutes, NaBH(OAc)3 (57.6 mg, 0.272 mmol) was added to reduce. After stirring for 30 minutes, the reaction mixture was diluted in saturated bicarbonate and EtOAc. The aqueous layer was back-extracted with DCM. The combined organic layer was washed with brine, dried with MgSO4, filtered and concentrated. Purification of the resulting crude material by reverse phase HPLC using a 0-100% acetonitrile/water gradient afforded afford 2-(1-ethyl-4-(4-(7-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-c]pyrimidin-5-yl)-1H-pyrazol-1-yl)piperidin-4-yl)acetonitrile (5.9 mg, 26% yield). MS (apci) m/z=416.2 (M+H).
後処理
- extractionThe aqueous layer was back-extracted with DCM
- washThe combined organic layer was washed with brine
- dry with materialdried with MgSO4
- filtrationfiltered
- concentrationconcentrated
- customPurification of the resulting crude material by reverse phase HPLC
- customgradient afforded
出典と根拠
- ORDレコード
- ord-411a28a4cf764084be8944435b3f94b6
- 出典データセット
- uspto-grants-2015_02
- 特許番号
- US08962596B2
反応ノート
読み込み中…